SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001510964-23-000022
Filing Date
2023-05-15
Accepted
2023-05-15 09:10:50
Documents
13
Period of Report
2023-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cvsi-20230515.htm   iXBRL 8-K 33230
2 EX-99.1 pressrelease05152023.htm EX-99.1 145639
  Complete submission text file 0001510964-23-000022.txt   315543

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cvsi-20230515.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cvsi-20230515_lab.xml EX-101.LAB 21368
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cvsi-20230515_pre.xml EX-101.PRE 10992
7 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20230515_htm.xml XML 9105
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

IRS No.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54677 | Film No.: 23918896
SIC: 2834 Pharmaceutical Preparations